Institute of Biomedical Research Corp.

Equities

MRES

US45781A1079

Market Closed - OTC Markets Other stock markets 02:35:05 2024-05-01 pm EDT			5-day change	1st Jan Change
0.0108 ^USD	-11.29%		-1.82%	+27.06%

Feb. 23	Institute of Biomedical Research Corp. Introduces M2BioKids	CI
Jan. 30	Real American Capital Corp. acquired M2MMA from Institute of Biomedical Research Corp..	CI

Institute of Biomedical Research Corp. acquired JDAX.

September 20, 2023

Institute of Biomedical Research Corp. (OTCPK:MRES) signed a letter of intent to acquire JDAX on June 27, 2023. The closing of the acquisition is expected to take place by July 31, 2023.

Institute of Biomedical Research Corp. (OTCPK:MRES) acquired JDAX on September 21, 2023. Immediately, JDAX will be rebranded with a new name and jurisdiction. The name will be announced in the coming weeks, and the new domicile for the company and IP will be Dubai, United Arab Emirates.

Latest news about Institute of Biomedical Research Corp.

Institute of Biomedical Research Corp. Introduces M2BioKids	Feb. 23	CI
Real American Capital Corp. acquired M2MMA from Institute of Biomedical Research Corp..	Jan. 29	CI
Institute of Biomedical Research Corp. Appoints Victor Lange as CEO of M2MMA	23-10-12	CI
Institute of Biomedical Research Corp. acquired JDAX.	23-09-20	CI
Institute of Biomedical Research Corp. Presents Update on its Latest Scientific Endeavor: M2Bio Sciences Endeavors to Usher in a Paradigm Shift Within the Realm of Medical Health by Focusing on the Foundational Facet of Drug Discovery	23-09-13	CI
Institute of Biomedical Research Corp. Appoints Ze-Ev Krein, an Interdisciplinary Scientist, and M2bio Scientific Advisory Board Chairman	23-09-13	CI
Institute of Biomedical Research Corp. Unveils a Line of Purple, White, and Green Teas from Kenya, Exhibiting Numerous Medicinal Health Benefits	23-07-17	CI
Institute of Biomedical Research Corp. signed a letter of intent to acquire JDAX.	23-06-26	CI
Institute of Biomedical Research Corp. Establishes Research Chair At the University of Pretoria for Phytomedicines	23-06-16	CI
Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	22-07-17	CI
Institute of Biomedical Research Corp. acquired Travel Mix Group Inc.	15-01-26	CI
Neuro-Biotech Corp. will Change its Name to The Institute of Biomedical Research Corp	14-04-28	CI
Institute of Biomedical Research acquired Neuro-Biotech Corp. in a reverse merger transaction.	14-01-30	CI

Chart Institute of Biomedical Research Corp.

Duration

Period

Chart Institute of Biomedical Research Corp.

More charts

Company Profile

Sector

More about the company